Glucokinase Activator for GCK-MODY Diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an experimental pill (a glucokinase activator) in adults with a specific genetic form of diabetes called GCK-MODY. The study aims to see if the pill can help control blood sugar without causing dangerously low sugar levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old.
- You have a confirmed genetic change (mutation) in the GCK gene that causes GCK-MODY.
- Your BMI is between 18 and 30.
- Your fasting blood sugar is above 5.6 mmol/L at screening.
- You have not taken certain diabetes medications in the last 6 weeks (like sulfonylureas, insulin, or GLP-1 agonists).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pill, dorzagliatin, to see how it affects insulin and blood sugar control in people with early type 2 diabetes or high blood sugar after a sugary drink. It may help improve blood sugar management.
This study tests an experimental diabetes pill (dorzagliatin) in people with type 2 diabetes and moderate to severe kidney problems. The goal is to see if it helps keep blood sugar levels stable and is safe for those with reduced kidney function.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This trial tests whether liraglutide, a once-daily injection, helps manage blood sugar in people with MODY diabetes. It's for those with high A1c levels and no prior use of similar drugs or certain health conditions.
This study tests an investigational pill (called cadisegliatin) added to your usual insulin treatment for people with type 1 diabetes who use an automated insulin pump. It aims to improve blood sugar control and reduce the time your sugar is too high.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.